Come join us over coffee and continental breakfast for a discussion of “State Opioid Taxes: Economic & Health Policy Implications!"
Alex Brill of Matrix Global Advisors will be discussing a white paper commissioned by Women In Government that addresses the burdens of the opioid epidemic on states and potential policy solutions.
Room 285, The Hall of the States
444 N. Capitol Street NW
Washington, DC 20001
Wednesday, January 23, 2019
9:00 AM to 10:30 AM
9:00 AM Registration & Breakfast
9:30 AM Program
10:00 AM Question & Answer Session
10:30 AM Adjournment
Please RSVP to Laura Blake, Outreach and Development Manager, if you would like to join us for this event.
Alex Brill is the founder and CEO of Matrix Global Advisors (MGA). Prior to founding MGA in 2007, Alex was the policy director and chief economist for the House Committee on Ways and Means, where he worked from 2002 to 2007. At the Ways and Means Committee, Alex directed policy development and led negotiations on a variety of tax, health, pension, and trade matters. Prior to his time on Capitol Hill, he served on the staff of the White House Council of Economic Advisers.
Alex has testified numerous times before Congress and has served as an expert witness and litigation consultant in both tax and pharmaceutical patent litigations. He has written and consulted on small-molecule generic drug competition, drug pricing, Part B reimbursement, generic drug labeling requirements, disease management, and the economic consequences of obesity and obesity mitigation, among other issues.
Alex is currently a resident fellow at the American Enterprise Institute.